protect hepat vaccin yupik eskimo popul seven-year result long-term immunogen protect plasma-deriv hepat vaccin heptavax cohort suscept person studi suscept person three-dos regimen hepat vaccin year vaccine antibodi surfac antigen anti-hb level miu/ml anti-hb level year age level anti-hb year first dose year first dose vaccin vaccin respond person antibodi core antigen level anti-hb none detect hepat surfac antigen clinic hepat updat ongo studi risk hepat viru infect person initi anti-hb respons viru vaccin miu/ml low initi antibodi level 